TRULICITY® 1.5 mg/0.5 mL contains dulaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist indicated for the treatment of type 2 diabetes mellitus in adults. It is supplied as a single-dose pre-filled pen for once-weekly subcutaneous injection.

Composition

• Active ingredient: Dulaglutide
• Strength: 1.5 mg per 0.5 mL
• Dosage form: Solution for injection
• Route of administration: Subcutaneous injection

Package Contents

• 1 single-dose pre-filled pen containing 0.5 mL solution
• Patient information leaflet

Indications

TRULICITY is indicated for:

• Improving glycemic control in adults with type 2 diabetes mellitus
• Use alongside diet and exercise
• Use as monotherapy or in combination with other antidiabetic medications
• Reducing the risk of major cardiovascular events in certain patients with type 2 diabetes and established cardiovascular disease, according to approved labeling

Key Features

• Once-weekly administration
• Ready-to-use, single-dose pre-filled pen
• No mixing or reconstitution required
• Simple injection device designed for ease of use
• Supports blood glucose control through GLP-1 receptor activation
• May assist with weight reduction in some patients

Administration

• Inject once weekly on the same day each week
• Administer subcutaneously into the abdomen, thigh, or upper arm
• Can be used with or without meals
• Follow the dosing schedule prescribed by a healthcare professional

Storage

• Store refrigerated at 2°C–8°C
• Do not freeze
• Keep in the original carton to protect from light
• Follow manufacturer recommendations for handling and storage

Packaging

• Product: TRULICITY®
• Active Substance: Dulaglutide
• Strength: 1.5 mg per 0.5 mL
• Presentation: Single-dose pre-filled pen
• Pack Size: 1 pre-filled pen

Manufacturer

• Eli Lilly and Company

Note: TRULICITY is a prescription medication and should only be used under the supervision of a qualified healthcare professional. Patients should follow prescribed dietary, exercise, and monitoring recommendations as part of their diabetes management plan.